Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Systematic adjudication of myocardial infarction end-points in an international clinical trial.
Mahaffey KW, Harrington RA, Akkerhuis M, Kleiman NS, Berdan LG, Crenshaw BS, Tardiff BE, Granger CB, DeJong I, Bhapkar M, Widimsky P, Corbalon R, Lee KL, Deckers JW, Simoons ML, Topol EJ, Califf RM; For the PURSUIT Investigators. Mahaffey KW, et al. Among authors: tardiff be. Curr Control Trials Cardiovasc Med. 2001 Jul 17;2(4):180-186. doi: 10.1186/cvm-2-4-180. Curr Control Trials Cardiovasc Med. 2001. PMID: 11806793 Free PMC article.
Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study.
Mahaffey KW, Harrington RA, Akkerhuis M, Kleiman NS, Berdan LG, Crenshaw BS, Tardiff BE, Granger CB, DeJong I, Bhapkar M, Widimsky P, Corbalon R, Lee KL, Deckers JW, Simoons ML, Topol EJ, Califf RM; For the PURSUIT Investigators. Mahaffey KW, et al. Among authors: tardiff be. Curr Control Trials Cardiovasc Med. 2001 Jul 17;2(4):187-194. doi: 10.1186/cvm-2-4-187. Curr Control Trials Cardiovasc Med. 2001. PMID: 11806794 Free PMC article.
Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II.
Tardiff BE, Califf RM, Tcheng JE, Lincoff AM, Sigmon KN, Harrington RA, Mahaffey KW, Ohman EM, Teirstein PS, Blankenship JC, Kitt MM, Topol EJ. Tardiff BE, et al. J Am Coll Cardiol. 1999 Jan;33(1):88-96. doi: 10.1016/s0735-1097(98)00551-8. J Am Coll Cardiol. 1999. PMID: 9935014 Free article. Clinical Trial.
Myonecrosis after revascularization procedures.
Califf RM, Abdelmeguid AE, Kuntz RE, Popma JJ, Davidson CJ, Cohen EA, Kleiman NS, Mahaffey KW, Topol EJ, Pepine CJ, Lipicky RJ, Granger CB, Harrington RA, Tardiff BE, Crenshaw BS, Bauman RP, Zuckerman BD, Chaitman BR, Bittl JA, Ohman EM. Califf RM, et al. Among authors: tardiff be. J Am Coll Cardiol. 1998 Feb;31(2):241-51. doi: 10.1016/s0735-1097(97)00506-8. J Am Coll Cardiol. 1998. PMID: 9462562 Free article. Review.
Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes.
Roe MT, Mahaffey KW, Kilaru R, Alexander JH, Akkerhuis KM, Simoons ML, Harrington RA, Tardiff BE, Granger CB, Ohman EM, Moliterno DJ, Lincoff AM, Armstrong PW, Van de Werf F, Califf RM, Topol EJ. Roe MT, et al. Among authors: tardiff be. Eur Heart J. 2004 Feb;25(4):313-21. doi: 10.1016/j.ehj.2003.12.009. Eur Heart J. 2004. PMID: 14984920 Free article. Clinical Trial.
Coronary revascularization surgery after myocardial infarction: impact of bypass surgery on survival after thrombolysis. GUSTO Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Tardiff BE, Califf RM, Morris D, Bates E, Woodlief LH, Lee KL, Green C, Rutsch W, Betriu A, Aylward PE, Topol EJ. Tardiff BE, et al. J Am Coll Cardiol. 1997 Feb;29(2):240-9. doi: 10.1016/s0735-1097(96)00492-5. J Am Coll Cardiol. 1997. PMID: 9014973 Free article. Clinical Trial.
Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II). Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis.
Thel MC, Califf RM, Tardiff BE, Gardner LH, Sigmon KN, Lincoff AM, Topol EJ, Kitt MM, Blankenship JC, Tcheng JE. Thel MC, et al. Among authors: tardiff be. Am J Cardiol. 2000 Feb 15;85(4):427-34. doi: 10.1016/s0002-9149(99)00767-5. Am J Cardiol. 2000. PMID: 10728945 Clinical Trial.
Reducing the costs of phase III cardiovascular clinical trials.
Eisenstein EL, Lemons PW 2nd, Tardiff BE, Schulman KA, Jolly MK, Califf RM. Eisenstein EL, et al. Among authors: tardiff be. Am Heart J. 2005 Mar;149(3):482-8. doi: 10.1016/j.ahj.2004.04.049. Am Heart J. 2005. PMID: 15864237
19 results